After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Bristol-Myers Squibb Co is listed on the NYSE as a member of the Healthcare sector and is a part of the Drug Manufacturers – General industry. The current market capitalization of Bristol-Myers Squibb Co is $99.29B. A total of 13.5 million shares were traded on the day, compared to an average of 14.85M shares.
In the most recent transaction, Hickey Benjamin sold 97 shares of BMY for 38.01 per share on May 09 ’25. After the transaction, the President, RayzeBio Org. now owns 0 company shares. In a previous transaction on Apr 25 ’25, Hirawat Samit bought 4,250 shares at 47.58 per share. BMY shares that EVP,Chief Med.Offr.,Drug Dev. owns now total 83,513.
Among the insiders who bought shares, BOERNER CHRISTOPHER S. acquired of 2,000 shares on Feb 20 ’25 at a per-share price of $55.05. This resulted in the Chief Executive Officer holding 104,626 shares of BMY after the transaction. In another insider transaction, Hirawat Samit bought 1,823 shares at $54.84 per share on Feb 14 ’25. Company shares held by the EVP,Chief Med.Offr.,Drug Dev. now total 63,932.
Dividend
It is more appealing for investors to invest in companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook for the company. Bristol-Myers Squibb Co pays an annual dividend of $2.44, resulting in a dividend yield of 5.00%, and it has a price to earnings (P/E) ratio of 18.32. BMY’s most recent ex-dividend date was 4.14% when it declared a $0.62 quarterly dividend that was paid in cash on 4/4/2025. Previously, the company paid the dividend on 1/3/2025 with an ex-dividend date of 4.38%. The BMY stock dividend was $0.62 per share in cash.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, BMY has a high of $63.33 and a low of $39.35.
As of this writing, BMY has an earnings estimate of $1.68 per share for the current quarter. EPS was calculated based on a consensus of 19.0 estimates, with a high estimate of $1.76 per share and a lower estimate of $1.52.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BMY’s latest balance sheet shows that the firm has $17.22B in Cash & Short Term Investments as of fiscal 2021. There were $45.60B in debt and $21.87B in liabilities at the time. Its Book Value Per Share was $8.54, while its Total Shareholder’s Equity was $36.01B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BMY is Buy with a score of 3.46.
